NLRP9
Basic information
Region (hg38): 19:55708438-55738402
Previous symbols: [ "NALP9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRP9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 72 | 83 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 72 | 10 | 7 |
Variants in NLRP9
This is a list of pathogenic ClinVar variants found in the NLRP9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-55708926-C-A | not specified | Uncertain significance (Oct 01, 2024) | ||
19-55708944-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
19-55708945-G-A | Likely benign (Oct 01, 2022) | |||
19-55709044-C-G | not specified | Likely benign (May 15, 2024) | ||
19-55711772-C-T | not provided (-) | |||
19-55711818-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
19-55711821-T-G | not specified | Uncertain significance (Oct 22, 2024) | ||
19-55711824-G-A | not specified | Uncertain significance (Feb 12, 2025) | ||
19-55711875-A-G | not specified | Uncertain significance (Jan 27, 2025) | ||
19-55711891-G-A | not provided (-) | |||
19-55711891-G-T | not specified | Uncertain significance (Mar 27, 2023) | ||
19-55711912-C-T | not specified | Uncertain significance (Mar 21, 2024) | ||
19-55711914-A-T | not specified | Uncertain significance (Oct 19, 2024) | ||
19-55711918-G-C | not specified | Uncertain significance (Dec 20, 2024) | ||
19-55711924-C-A | not specified | Likely benign (Feb 10, 2025) | ||
19-55711927-C-T | not specified | Uncertain significance (Mar 08, 2025) | ||
19-55711933-C-T | not specified | Uncertain significance (Feb 19, 2025) | ||
19-55711948-G-A | Benign (Jul 17, 2018) | |||
19-55711948-G-C | not specified | Uncertain significance (Mar 30, 2022) | ||
19-55711956-G-A | not specified | Uncertain significance (Aug 04, 2021) | ||
19-55712306-G-A | not provided (-) | |||
19-55712422-G-A | Benign (Dec 31, 2019) | |||
19-55712429-T-A | not specified | Uncertain significance (Feb 21, 2024) | ||
19-55712430-C-G | not specified | Uncertain significance (Jul 08, 2022) | ||
19-55712463-A-G | not specified | Uncertain significance (Jan 27, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NLRP9 | protein_coding | protein_coding | ENST00000332836 | 9 | 29971 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.86e-25 | 0.000455 | 125314 | 2 | 432 | 125748 | 0.00173 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.643 | 564 | 523 | 1.08 | 0.0000269 | 6555 |
Missense in Polyphen | 114 | 120.71 | 0.94437 | 1771 | ||
Synonymous | -1.66 | 244 | 213 | 1.14 | 0.0000125 | 1845 |
Loss of Function | 0.0291 | 37 | 37.2 | 0.995 | 0.00000191 | 492 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00390 | 0.00382 |
Ashkenazi Jewish | 0.00233 | 0.00228 |
East Asian | 0.00439 | 0.00430 |
Finnish | 0.0000473 | 0.0000462 |
European (Non-Finnish) | 0.00124 | 0.00123 |
Middle Eastern | 0.00439 | 0.00430 |
South Asian | 0.00316 | 0.00304 |
Other | 0.00116 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: As the sensor component of the NLRP9 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens, including rotavirus, initiates the formation of the inflammasome polymeric complex, made of NLRP9, PYCARD and CASP1. Recruitment of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and release in the extracellular milieu. The active cytokines stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death. NLRP9 inflammasome activation may be initiated by DHX9 interaction with viral double-stranded RNA (dsRNA), preferentially to short dsRNA segments. {ECO:0000269|PubMed:28636595}.;
Recessive Scores
- pRec
- 0.0823
Intolerance Scores
- loftool
- 0.693
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 45.68
Haploinsufficiency Scores
- pHI
- 0.0815
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nlrp9b
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; immune system phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- inflammatory response;positive regulation of interleukin-18 production;innate immune response;defense response to virus;pyroptosis
- Cellular component
- inflammasome complex
- Molecular function
- protein binding;ATP binding